China Resources Pharmaceutical Group Limited (FRA:640)

FRA:640 Revenue

China Resources Pharmaceutical Group had revenue of 131.87B CNY in the half year ending June 30, 2025, with 7.37% growth. This brings the company's revenue in the last twelve months to 260.94B, up 4.18% year-over-year. In the year 2024, China Resources Pharmaceutical Group had annual revenue of 257.67B with 5.30% growth.

• Revenue (ttm): 260.94B CNY
• Revenue Growth: +4.18%
• P/S Ratio: 0.11
• Revenue / Employee: 3.59M CNY
• Employees: 72,700
• Market Cap: 3.42B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	257.67B	12.97B	5.30%
Dec 31, 2023	244.70B	26.52B	12.16%
Dec 31, 2022	218.18B	25.26B	13.10%
Dec 31, 2021	192.92B	24.16B	14.31%
Dec 31, 2020	168.76B	-14.00B	-7.66%